The efficacy and tolerability of ultra-hypofractionated radiotherapy in low-intermediate risk prostate cancer patients: single center experience.

Selvi Dinçer Emre Uysal Tanju Berber Mustafa Halil Akboru

Published in: The aging male : the official journal of the International Society for the Study of the Aging Male (2021)

Our data demonstrated that UHRT administered with volumetric arc therapy (VMAT) can be recommended for selected patients with low-intermediate risk prostate cancer. Further prospective, multicentric, controlled trials on larger series are warranted to reach more accurate conclusions.

Keyphrases

prostate cancer
radiation therapy
radical prostatectomy
high resolution
randomized controlled trial
small cell lung cancer
open label
radiation induced
stem cells
clinical trial
machine learning
cell therapy
data analysis
replacement therapy